Murray Stahl's MRK Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 28,617 shares of Merck & Co., Inc. (MRK) worth $2.4 M, representing 0.03% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Murray Stahl has maintained a long-term strategic position in MRK, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2024, adding 7,258 shares. Largest reduction occurred in Q1 2023, reducing 8,099 shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's Merck & Co (MRK) Holding Value Over Time
Track share changes against reported price movement
Quarterly Merck & Co (MRK) Trades by Murray Stahl
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +50,694 | Add 0.00% | 50,693 | $44.33 |
| Q3 2013 | -262 | Reduce 0.52% | 50,431 | $45.43 |
| Q4 2013 | -53 | Reduce 0.11% | 50,378 | $47.76 |
| Q1 2014 | -21 | Reduce 0.04% | 50,357 | $54.17 |
| Q2 2014 | +231 | Add 0.46% | 50,588 | $55.21 |
| Q3 2014 | -1,520 | Reduce 3.00% | 49,068 | $56.55 |
| Q4 2014 | -21 | Reduce 0.04% | 49,047 | $54.19 |
| Q1 2015 | -6,026 | Reduce 12.29% | 43,021 | $54.86 |
| Q2 2015 | +105 | Add 0.24% | 43,126 | $54.33 |
| Q3 2015 | +2,222 | Add 5.15% | 45,348 | $47.12 |
| Q4 2015 | -252 | Reduce 0.56% | 45,096 | $50.40 |
| Q1 2016 | +2,585 | Add 5.73% | 47,681 | $50.50 |
| Q4 2016 | +2,497 | Add 5.24% | 50,178 | $56.18 |
| Q1 2017 | -1,630 | Reduce 3.25% | 48,548 | $60.62 |
| Q2 2017 | +3,079 | Add 6.34% | 51,627 | $61.15 |
| Q3 2017 | -412 | Reduce 0.80% | 51,215 | $61.10 |
| Q4 2017 | -1,383 | Reduce 2.70% | 49,832 | $53.70 |
| Q1 2018 | +115 | Add 0.23% | 49,947 | $51.98 |
| Q2 2018 | -344 | Reduce 0.69% | 49,603 | $57.92 |
| Q4 2018 | -703 | Reduce 1.42% | 48,900 | $72.90 |
| Q1 2019 | +48,343 | Add 0.00% | 48,342 | $79.35 |
| Q2 2019 | +739 | Add 1.53% | 49,081 | $80.01 |
| Q3 2019 | -1,690 | Reduce 3.44% | 47,391 | $80.33 |
| Q4 2019 | -1,101 | Reduce 2.32% | 46,290 | $86.78 |
| Q1 2020 | -830 | Reduce 1.79% | 45,460 | $73.41 |
| Q2 2020 | -3,537 | Reduce 7.78% | 41,923 | $73.78 |
| Q3 2020 | +912 | Add 2.18% | 42,835 | $79.14 |
| Q4 2020 | -3,936 | Reduce 9.19% | 38,899 | $78.05 |
| Q1 2021 | +248 | Add 0.64% | 39,147 | $73.57 |
| Q2 2021 | -3,394 | Reduce 8.67% | 35,753 | $77.78 |
| Q3 2021 | -358 | Reduce 1.00% | 35,395 | $75.12 |
| Q4 2021 | +2 | Add 0.01% | 35,397 | $76.64 |
| Q1 2022 | +102 | Add 0.29% | 35,499 | $82.06 |
| Q2 2022 | -356 | Reduce 1.00% | 35,143 | $91.17 |
| Q3 2022 | +559 | Add 1.59% | 35,702 | $86.13 |
| Q4 2022 | -441 | Reduce 1.24% | 35,261 | $110.95 |
| Q1 2023 | -8,099 | Reduce 22.97% | 27,162 | $106.39 |
| Q2 2023 | -499 | Reduce 1.84% | 26,663 | $115.39 |
| Q3 2023 | +376 | Add 1.41% | 27,039 | $102.95 |
| Q4 2023 | -498 | Reduce 1.84% | 26,541 | $109.02 |
| Q1 2024 | -580 | Reduce 2.19% | 25,961 | $131.95 |
| Q2 2024 | -27 | Reduce 0.10% | 25,934 | $123.80 |
| Q3 2024 | +7,258 | Add 27.99% | 33,192 | $113.56 |
| Q4 2024 | +382 | Add 1.15% | 33,574 | $99.48 |
| Q1 2025 | +500 | Add 1.49% | 34,074 | $89.76 |
| Q2 2025 | +1,761 | Add 5.17% | 35,835 | $79.16 |
| Q3 2025 | -7,218 | Reduce 20.14% | 28,617 | $83.93 |
Murray Stahl's Merck & Co Investment FAQs
Murray Stahl first purchased Merck & Co., Inc. (MRK) in Q2 2013, acquiring 50,693 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl has held Merck & Co., Inc. (MRK) for 50 quarters since Q2 2013.
Murray Stahl's largest addition to Merck & Co., Inc. (MRK) was in Q2 2013, adding 50,693 shares worth $2.25 M.
According to the latest 13F filing for Q3 2025, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 28,617 shares of Merck & Co., Inc. (MRK), valued at approximately $2.4 M.
As of the Q3 2025 filing, Merck & Co., Inc. (MRK) represents approximately 0.03% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings.
Murray Stahl's peak holding in Merck & Co., Inc. (MRK) was 51,627 shares, as reported at the end of Q2 2017.